Colonial Trust’s Halozyme HALO Stock Holding History

Colonial Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.48K	Hold	70	–	–	﹤0.01%	845
2026 Q1	$4.52K	Buy	70 +9	+15%	+$634	﹤0.01%	867
2025 Q4	$4.11K	Buy	+61	New	+$4.1K	﹤0.01%	879

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Colonial Trust's HALO Position: Q2 2026 in Review

Colonial Trust held its Halozyme (HALO) position steady in Q2 2026 at 70 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #845.

Colonial Trust first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Colonial Trust held 70 shares of Halozyme worth $5.48K as of Q2 2026.
Colonial Trust left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #845 holding.
Colonial Trust first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.